Fundraising FoxGenesys Capital — Full Portfolio
22 tracked investments · listed companies and verified rows first
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)
Co-investorsCTI Life Sciences Fund L.P.FACIT (Fight Against Cancer Innovation Trust)
Adapsyn Bioscience is a biotech company focused on discovering and developing microbial natural product small molecules for therapeutic applications by leveraging genomic and chemical biology approaches.
AI & Machine LearningBiotechDeep TechHamilton, CA
Nathan Magarvey(Founder)
Co-investorsPfizer Venture Investments
Antegrade Medical is a Quebec City-based medical device startup developing single-use procedural tools enabling an antegrade approach for structural interventional cardiology procedures.
Cresta provides a unified platform combining human and AI agents to automate and augment customer service interactions for enterprise contact centers.
AI & Machine LearningEnterprise SoftwareSaaSSales TechSunnyvale, US
Sebastian Thrun(Founder)inTim Shi(Founder)inZayd Enam(Founder)inAndre Esteva(Founder)inShan Huang(Co-Founder)inPing Wu(Chief Executive Officer)in
Co-investorsAndreessen HorowitzTiger Global ManagementBallistic VenturesBrilliant Phoenix CapitalComcast VenturesGreylock Partners+17 more
Leading paint manufacturer in Ghana focused on West African exports.
Co-investorsAdenia PartnersAccenture VenturesAndreessen HorowitzGreylock PartnersLG Technology VenturesQualcomm Ventures+5 more
Cryostasis develops the Woolii SU (Subzero Unfrozen) platform, a preservation system that stores cell therapy products at subzero temperatures without freezing or cryoprotectants.
BiotechDeep TechHardwareHealthtechMedical Devices
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in
Co-investorsSV Health InvestorsToronto Innovation Acceleration Partners
Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment.
HealthtechMedical Devices
Co-investorsJobsOhio Ventures
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.
BiotechDeep TechMedical Devices
François-Thomas Michaud(Board Member & Chief Executive Officer)in
Co-investorsAsahi Kasei Corporate Venture CapitalLinearis VenturesFonds de solidarité FTQZynext Ventures
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesiGan PartnersNew Leaf Venture PartnersRBCx
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesPivotal Life SciencesSeroba Life SciencesVenture Ontario+6 more
Scalable, high throughput DNA sequencing platforms.
Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovationsAmgen Ventures+2 more
This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms.
Biotech
Co-investorsCDP Venture CapitalIreland Strategic Investment FundAdams Street PartnersHealthCapOrbiMedPivotal Life Sciences+1 more
Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
Co-investorsAlumni VenturesHatteras Venture PartnersPappas CapitalSanofi VenturesAlexandriaJDRF T1D Fund+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Adapsyn Bioscience IncFunction NeuromodulationFusionGiiantGiiant Pharma IncQuestat IncVeralox Therapeutics Inc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.